Procter & Gamble reported weak fiscal year 2026 results with only 1% organic sales and core earnings per share growth. The company forecasts modest 1–3% organic sales growth for fiscal year 2027 amid challenges from rising private label competition, cost pressures, and a significant $1 billion after-tax headwind. Despite these issues, P&G maintains strong free cash flow and a roughly 3% dividend yield. The recent $3.8 billion acquisition of Thorne aims to diversify growth but carries risks due to the premium paid. Overall, the current share price reflects fair value amid growing macroeconomic uncertainty, leading analysts to maintain a Hold rating.
Four Dividend Kings—Johnson & Johnson, Procter & Gamble, Coca-Cola, and PepsiCo—continue to deliver steady dividends, crucial for retirees relying on portfolio income. Johnson & Johnson and Procter & Gamble show very safe dividend payouts with health...
Five major U.S. companies—Coca-Cola, Procter & Gamble, Johnson & Johnson, PepsiCo, and Realty Income—are highlighted for their long histories of dividend increases and strong cash flow coverage. These firms offer diverse dividend yields, with some pr...
Procter & Gamble leads with 70 years of consecutive dividend increases, joined by Johnson & Johnson, Coca-Cola, ADP, and Lowe's, each maintaining solid payout ratios and strong cash flow coverage. These companies demonstrate resilience through recess...
Johnson & Johnson and Procter & Gamble are both Dividend Kings with similar valuations, but Johnson & Johnson is favored for long-term dividend growth due to better dividend coverage, lower payout ratio, and stronger growth prospects despite P&G's lo...
